Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hologic's annualizedGross Profit for the quarter that ended in Dec. 2023 was $2,270 Mil.
Hologic's average Total Assets over the quarter that ended in Dec. 2023 was $8,804 Mil. Therefore, Hologic's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 25.78%.
Hologic Gross-Profit-to-Asset % Historical Data
The historical data trend for Hologic's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hologic's Gross-Profit-to-Asset %
For the Medical Instruments & Supplies subindustry, Hologic's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Hologic's Gross-Profit-to-Asset % falls into.
Hologic Gross-Profit-to-Asset % Calculation
Hologic's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Hologic Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Hologic's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HOLX has been successfully added to your 